Retinopathy of prematurity (ROP) is a retinal vasoproliferative disease that affects premature
infants. Despite improvements in neonatal care and management guidelines, ROP remains …

Background Infants born extremely preterm (< 28 weeks gestational age (GA)) face a high
risk of neonatal mortality. Bronchopulmonary dysplasia (BPD) is the most common morbidity …

Retinopathy of prematurity (ROP) is among the most common causes of childhood
blindness. Three phases of ROP epidemics have been observed worldwide since ROP was …

Background: Recombinant human erythropoietin (rhEPO) lost its role in minimizing red
blood cell transfusion in very preterm infants after it had been associated with severe …

Objectives To conduct a systematic literature review to evaluate the global incidence of
intraventricular hemorrhage grade 2–4 among extremely preterm infants. Methods We …

Aim: The aim of this study is to examine possible associations between the transfusion of
RBC or platelets (PLTs) and the development of retinopathy of prematurity (ROP) in infants …

(1) Background: Retinopathy of prematurity (ROP) can cause severe visual impairment or
even blindness. We aimed to assess the hematological risk factors that are associated with …

The review aims to evaluate the uses of conventional laser therapy and intravitreal injection
of various anti-VEGF in terms of efficacy and side effects for the treatment of retinopathy of …

Background Retinopathy of prematurity (ROP) is a vascular proliferative disorder of the
develo** retina and a significant cause of childhood blindness around the world. The …

Introduction: Increased survival of preterm babies in sub-saharan Africa has held to an
increasing prevalence of Retinopathy of prematurity (ROP). This study was done to …